Drug Profile
Funapide - Flexion Therapeutics
Alternative Names: FX 301; PCRX-301; TV 45070; XEN-402; XPF 002; XPF-001Latest Information Update: 11 Mar 2024
Price :
$50
*
At a glance
- Originator Xenon Pharmaceuticals
- Developer Flexion Therapeutics; Teva Pharmaceutical Industries; Xenon Pharmaceuticals
- Class Benzodioxoles; Fluorobenzenes; Furans; Indoles; Non-opioid analgesics; Small molecules; Spiro compounds; Vascular disorder therapies
- Mechanism of Action Nav1.7 voltage-gated sodium channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Dental pain; Erythromelalgia; Musculoskeletal pain; Neuropathic pain; Pain; Postherpetic neuralgia; Postoperative pain